Sunshine Biopharma (SBFM) Shares Outstanding (2017 - 2026)

Sunshine Biopharma's Shares Outstanding (Entity) history runs 4 years deep, the most recent figure standing at $1217.0 for Q4 2023.

• Quarterly Shares Outstanding (Entity) rose 60.34% year-over-year to $1217.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1217.0 (up 60.34% YoY) and the FY2023 annual result came in at $1217.0, up 60.34% from the prior year.
• Shares Outstanding (Entity) was $1217.0 for Q4 2023 at Sunshine Biopharma, down from $1284.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1287.0 in Q2 2023 and bottomed at $9.0 in Q1 2020.
• A 4-year average of $529.06 and a median of $197.0 in 2021 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) jumped 1188.89% — and 2023, when it jumped 36.02%.
• Sunshine Biopharma's Shares Outstanding (Entity) stood at $51.0 in 2020, then jumped by 154.9% to $130.0 in 2021, then surged by 483.85% to $759.0 in 2022, then jumped by 60.34% to $1217.0 in 2023.
• Business Quant data shows SBFM's Shares Outstanding (Entity) at $1217.0 in Q4 2023, $1284.0 in Q3 2023, and $1287.0 in Q2 2023.